Proximus NV
SWB:BX7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Proximus NV
SWB:BX7
|
BE |
|
O
|
OHB SE
XMUN:OHB
|
DE |
|
Unicaja Banco SA
F:7UB
|
ES |
|
T
|
Tribhovandas Bhimji Zaveri Ltd
BSE:534369
|
IN |
|
W
|
Woodside Petroleum Ltd
F:WOPA
|
AU |
|
A
|
Aegean Airlines SA
F:32A
|
GR |
|
S
|
SBI Holdings Inc
XBER:ZOF
|
JP |
|
M
|
Mogo Inc
F:SGCC
|
CA |
|
W
|
West Pharmaceutical Services Inc
SWB:WPS
|
US |
|
C
|
CRISPR Therapeutics AG
F:1CG
|
CH |
|
P
|
Poolbeg Pharma PLC
F:7JN
|
UK |
|
B
|
Brookside Energy Ltd
XBER:8F3
|
AU |
|
Japan Aviation Electronics Industry Ltd
OTC:JPAVF
|
JP |
Wall St Price Targets
BX7 Price Targets Summary
Proximus NV
According to Wall Street analysts, the average 1-year price target for BX7 is 7.67 EUR with a low forecast of 6.2 EUR and a high forecast of 10.28 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BX7's stock price target?
Price Target
7.67
EUR
According to Wall Street analysts, the average 1-year price target for BX7 is 7.67 EUR with a low forecast of 6.2 EUR and a high forecast of 10.28 EUR.
What is the Revenue forecast for Proximus NV?
Projected CAGR
-1%
Over the last 14 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 5 years is -1%.
What is the Operating Income forecast for Proximus NV?
Projected CAGR
-6%
Over the last 14 years, the compound annual growth rate for Operating Income has been -4%. The projected CAGR for the next 3 years is -6%.
What is the Net Income forecast for Proximus NV?
Projected CAGR
-4%
Over the last 14 years, the compound annual growth rate for Net Income has been -4%. The projected CAGR for the next 3 years is -4%.
